RNA, DNA, and cell surface characteristics of lesional and nonlesional psoriatic skin
- PMID: 2437219
- DOI: 10.1111/1523-1747.ep12470257
RNA, DNA, and cell surface characteristics of lesional and nonlesional psoriatic skin
Abstract
We have measured the RNA and DNA content and examined cell surface characteristics of human epidermal cells derived from normal skin, and lesional and nonlesional areas of psoriatic skin prior to and following treatment on a modified Goeckerman protocol. Our results show that cells from active psoriatic lesions contain greater numbers of basal keratinocytes when compared with either nonlesional skin from the same patients or skin from healthy volunteers and individuals with other inflammatory skin lesions. Follow-up measurements 2-3 weeks after the initiation of therapy showed that the numbers of basal keratinocytes in resolving psoriatic lesions had decreased and approached normal levels. Multiparameter RNA/DNA flow cytometric analysis on parallel samples from the same psoriasis patients revealed an increased growth fraction and proportion of cycling cells in both the nonlesional and lesional skin compared with controls. Furthermore, the cellular RNA content was elevated in lesional psoriatic skin when compared with either nonlesional or normal skin. Flow cytometric examination of nonlesional and lesional epidermal cells obtained 2-3 weeks after the commencement of therapy revealed that the growth fraction and mean RNA content of the keratinocytes from resolving psoriatic plaques decreased in response to therapy. In contrast, the proportion of keratinocytes within the S + G2 + M phases of the cell cycle remained elevated. These data indicate that "uninvolved" psoriatic skin exhibits characteristics more closely resembling lesional psoriatic skin than normal skin. The results further suggest that quantitation of cellular RNA content and basal cell number might be sensitive indicators of early treatment response in psoriasis.
Similar articles
-
Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis.J Exp Med. 1993 Oct 1;178(4):1271-81. doi: 10.1084/jem.178.4.1271. J Exp Med. 1993. PMID: 7690831 Free PMC article.
-
The level of prosaposin is decreased in the skin of patients with psoriasis vulgaris.J Invest Dermatol. 2001 Mar;116(3):394-400. doi: 10.1046/j.1523-1747.2001.01283.x. J Invest Dermatol. 2001. PMID: 11231313
-
Flow cytometric analysis of epidermal subpopulations from normal and psoriatic skin using monoclonal antibodies against intermediate filaments.Am J Pathol. 1989 Nov;135(5):865-70. Am J Pathol. 1989. PMID: 2479273 Free PMC article.
-
Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia.J Invest Dermatol. 1995 Jul;105(1 Suppl):89S-94S. doi: 10.1111/1523-1747.ep12316121. J Invest Dermatol. 1995. PMID: 7616005 Review.
-
Psoriasis is a disease of the entire skin: non-lesional skin displays a prepsoriasis phenotype.Eur J Dermatol. 2021 Apr 1;31(2):143-154. doi: 10.1684/ejd.2021.4015. Eur J Dermatol. 2021. PMID: 34001466 Review.
Cited by
-
The rate of wound healing is increased in psoriasis.J Dermatol Sci. 2013 Nov;72(2):87-92. doi: 10.1016/j.jdermsci.2013.06.001. Epub 2013 Jun 12. J Dermatol Sci. 2013. PMID: 23819987 Free PMC article.
-
Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques.J Exp Med. 1988 Sep 1;168(3):941-8. doi: 10.1084/jem.168.3.941. J Exp Med. 1988. PMID: 2459293 Free PMC article.
-
Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis.J Exp Med. 1993 Oct 1;178(4):1271-81. doi: 10.1084/jem.178.4.1271. J Exp Med. 1993. PMID: 7690831 Free PMC article.
-
Immunohistochemical localization of calmodulin in normal and psoriatic epidermis.Arch Dermatol Res. 1989;280(8):497-8. doi: 10.1007/BF00427664. Arch Dermatol Res. 1989. PMID: 2645837 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical